|
15 Apr 2013
NeurOp Receives Second Half of NIH Grant for Meeting Schizophrenia Research Milestones
NeurOp, Inc. has received $346,000 from the National Institutes of Health (NIH), the second half of a $700,000 grant made last year to support its schizophrenia treatment research. NeurOp is studying ...
Read More
|
19 Feb 2013
NeurOp and Emory Scientists Target Cognitive and Mental Health Disorders
NeurOp, Inc. has formed a research collaboration with Emory University to study modulation of certain brain cell receptors and its possible impact on several serious cognitive and mental health disord ...
Read More
|
6 Sep 2012
NeurOp Receives $1 Million in NIH Funding for Ischemia Research
NeurOp, Inc. has received $1 million in funding as part of a $3 million National Institutes of Health (NIH) award to support its cerebral ischemia research program. First announced in July 2011, the g ...
Read More
|
16 Apr 2012
NeurOp Names Robert Zaczek as Chief Scientific Officer
NeurOp, Inc. today announced that Robert Zaczek, Ph.D., has been named its chief scientific officer, a new role for the company. He will oversee the company’s drug research, which is focused on NMDA r ...
Read More
|
11 Apr 2012
NeurOp Awarded $700,000 Grant for Schizophrenia Drug Research
NeurOp, Inc. today announced that the National Institutes of Health (NIH) has awarded it a $700,000 grant to support its research for new schizophrenia treatments. NeurOp will use the funding to suppo ...
Read More
|
|